- Microfluidics News Admin
[Conference]Rapid antibiotic susceptibility test: Commercialization of life saving MEMS devices
Abstract:
For the timely treatment of patients with infections in bloodstream and cerebrospinal fluid, a rapid antimicrobial susceptibility test (AST) is urgently needed. This paper describe a direct and rapid antimicrobial susceptibility testing (dRAST) system, which can determine the antimicrobial susceptibility of bacteria from a positive blood culture bottle (PBCB) in six hours that conventionally taking more than 30–50 hours. Design consideration, clinical verification, commercialization, and application of dRAST system to tuberculosis are reviewed.
Published in: Micro Electro Mechanical Systems (MEMS), 2017 IEEE 30th International Conference on
Date of Conference: 22-26 Jan. 2017
Date Added to IEEE Xplore: 28 February 2017
DOI: 10.1109/MEMSYS.2017.7863349
Hyun Yong Jeong
Seoul National University, Seoul, REPUBLIC OF Korea
Eun-Geun Kim
Quantamatrix Inc., Seoul, REPUBLIC OF Korea
Sangkwon Han
Quantamatrix Inc., Seoul, REPUBLIC OF Korea
Gi Yoon Lee
Seoul National University, Seoul, REPUBLIC OF Korea
Shinhoon Han
Quantamatrix Inc., Seoul, REPUBLIC OF Korea
Bonghwan Jin
Quantamatrix Inc., Seoul, REPUBLIC OF Korea
Taegeun Lim
Seoul National University, Seoul, REPUBLIC OF Korea
Hee Chan Kim
Seoul National University Hospital, Seoul, REPUBLIC OF Korea
Taek Soo Kim
Seoul National University Hospital, Seoul, REPUBLIC OF Korea
Dongyoung Kim
Seoul National University, Seoul, REPUBLIC OF Korea
Sunghoon Kwon
Seoul National University, Seoul, REPUBLIC OF Korea
Link: http://ieeexplore.ieee.org/abstract/document/7863349/
#susceptibility #infectiousdisease #Biologicalapplication #MEMS